FCGR3A and head and neck squamous cell carcinoma: To explore exosome-mediated immune modulation within the TME, we asked whether the Fcγ receptor CD16 is present on exosomes from plasma of HNSCC patients, whether CD16 is differentially present on TEX compared to total exosomes, and if CD16 levels on exosomes correlate with clinicopathological parameters.